Open Label Study Telmisartan and Amlodipine in Hypertension

NCT00614380 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

976

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: telmisartan/amlodipine 40/5 mg fixed combination
DRUG: telmisartan/amlodipine 80/5 mg fixed combination

Sponsor

Boehringer Ingelheim